Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has repurchased a total of 1,070,000 ordinary shares for approximately £13.2 million during the period of March 23 to March 27, 2026, as part of its $250 million share repurchase program. These repurchased shares are intended for cancellation. Since the program's inception on February 26, 2026, Hikma has bought back 3,761,014 shares for £46.9 million. Following these transactions, the company holds 12,833,233 shares in treasury, with 218,125,439 ordinary shares in issue, resulting in a total of 218,125,439 voting rights.

Disclaimer*

UK 100

Latest directors dealings